文献速递呼吸道感染慢阻肺

多重耐药革兰阴性菌对呼吸道感染的威胁

The respiratory threat posed by multidrug resistant Gram-negative bacteria.
PubMed 文献 · Respirology · 2017-07-06

综述回顾了多重耐药(MDR)革兰阴性杆菌(GNB)在社区获得性肺炎、医院获得性肺炎、慢阻肺及支气管扩张等呼吸道感染中的流行情况与临床影响。MDR-GNB在亚太、欧洲和美国均有报告,医院获得性感染中比例可达70%;其存在与不良临床结局(包括死亡率升高)相关,但相关数据有限,可能与经验性抗生素选择不当有关。

要点

  • 铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌和鲍曼不动杆菌是呼吸道感染常见MDR-GNB病原。
  • MDR-GNB流行率随地域变化,医院获得性感染中报告比例可达70%。
  • MDR-GNB与不良结局相关,经验性抗生素选择不当可能是重要环节。

核心结论

  • MDR-GNB在多种呼吸道感染中已被检出,并与不良临床结局相关,但相关数据有限。
  • GNB耐药且缺乏新抗生素使治疗选择受限,是需要未来研究的重要问题。

研究设计与样本

  • 综述类:回顾当前文献,汇总MDR-GNB在不同呼吸道感染中的流行率及其对临床结局的影响。

主要发现

  • 社区获得性和医院获得性肺炎患者中检测到MDR-GNB。
  • 慢阻肺和支气管扩张伴急性或慢性支气管感染患者中也分离出MDR-GNB。
  • MDR-GNB在亚太地区、欧洲和美国均有报告,医院获得性感染中比例可达70%。
  • MDR-GNB的存在与不良临床结局相关,包括死亡率升高,但数据有限。

关键数值与推荐

  • 医院获得性感染中MDR-GNB报告比例可达70%。

临床怎么用

  • 呼吸道感染经验性抗感染治疗需考虑当地MDR-GNB流行情况,避免选择不当。

局限性

  • MDR-GNB与不良结局关系的数据有限。
  • 流行率随地理区域变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory infections are a major cause of global mortality and morbidity. In recent years, an increased incidence of multidrug-resistant (MDR) Gram-negative bacteria (GNB) has been described. Microorganisms such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae or Acinetobacter baumannii have been identified as causative pathogens of different respiratory tract infections. Several studies have detected MDR-GNB in patients with community-acquired and nosocomial pneumonia. Furthermore, MDR-GNB have also been isolated in patients with chronic obstructive pulmonary disease and bronchiectasis having acute or chronic bronchial infection. Prevalence varies depending on the geographical area but MDR-GNB has been reported in the Asia-Pacific region, Europe and the United States, reaching rates of 70% in hospital-acquired infection. The presence of MDR-GNB has been related to poor clinical outcomes, including increased mortality, although data regarding this relationship are limited. This is probably linked to inappropriate selection of empiric antibiotic treatment; this poses a threat of widespread resistance. GNB antibiotic resistance and the absence of new antibiotics are a major concern given limited treatment options; an aspect that deserves future research. We review current literature, highlight prevalence of MDR-GNB in different respiratory infections and explore their impact on clinical outcomes.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Rodrigo-Troyano A, Sibila O. The respiratory threat posed by multidrug resistant Gram-negative bacteria. Respirology. 2017. PMID: 28681941. doi:10.1111/resp.13115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。